50% off all subscriptions! ... left. Order NowOrder Now

$3.25 (0%)

Volume: 7k

Closed: Nov 26, 2021

Hollow Logo Score: -2.709

Benitec Biopharma Limited Stock Forecast

$3.25 (0%)

Volume: 7k

Closed: Nov 26, 2021

Score Hollow Logo -2.709
Which way will BNTC go? Request
Key Stats
Beta 0.12
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 33 and the stock is currently not being overbought or oversold

Evaluation of Benitec Biopharma Limited stock downgraded after the last trading session.
(Updated on Nov 26, 2021)


Sell candidate since 2021-11-26

No changes to the price of Benitec Biopharma Limited stock on the last trading day (Friday, 26th Nov 2021). During the day the stock fluctuated 4.43% from a day low at $3.16 to a day high of $3.30. The price has fallen in 6 of the last 10 days and is down by -5.8% for this period.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.56% during the next 3 months and, with a 90% probability hold a price between $2.52 and $3.04 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, November 23, 2021, and so far it has risen 8.33%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Benitec Biopharma Limited stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $3.52. On a fall, the stock will find some support from the short-term average at $3.21. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss

Benitec Biopharma Limited finds support from accumulated volume at $3.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.14 between high and low, or 4.43%. For the last week the stock has had a daily average volatility of 7.82%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Benitec Biopharma Limited stock A Buy?

Benitec Biopharma Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -2.709

Predicted Opening Price for Benitec Biopharma Limited of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$3.24 $3.25 (Overvalued)
Sell Candidate Downgraded

Remember To Visit Our YouTube Channel

Analyst Ratings

LADENBURG THALM/SH SH is very positive about BNTC and gave it a "Buy" rating on Apr 20, 2020. The price target was set to $14.00.

Volatility and Risk
Daily Average Volatility: 7.82 %
Overall Risk: Very High High Medium Low Very Low
Volatility
7.82 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $3.57
Price: $3.25
Support: $3.20

BNTC Insider Trading Show all Trades

INSIDER POWER

Last 5 transactions
Buy: 497 320 | Sell: 0 (Shares)
Date Action Amount Person Type
Dec 09, 2020 Buy 142 172 Boston Megan Options (right to buy)
Dec 09, 2020 Buy 23 601 Smith Edward F Options (right to buy)
Dec 09, 2020 Buy 23 601 Francis Peter Options (right to buy)
Dec 09, 2020 Buy 23 601 Buchi J Kevin Options (right to buy)
Dec 09, 2020 Buy 284 345 Banks Jerel A. Options (right to buy)
Show all Insider Trades
INSIDER POWER

Last 5 transactions
Buy: 497 320 | Sell: 0 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 3.38 3.90 %
3.32 2.25 %
3.29 1.24 %
Current price: 3.25
Support 3.18 -2.06 %
3.15 -3.07 %
3.10 -4.72 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 3.96 21.85 %
3.87 19.08 %
3.57 9.85 %
Current price 3.25
Support 3.20 -1.54%
3.16 -2.77%
3.00 -7.69%

Click to get the best stock tips daily for free!

About Benitec Biopharma Limited

Benitec Biopharma Limited Benitec Biopharma Limited, a biotechnology company, develops treatments for chronic and life-threatening human diseases based on its gene silencing technology, DNA-directed RNA interference (ddRNAi) in Australia. Its in-house development programs include TT-034, which is in Phase I/IIa clinical trials for the treatment of hepatitis C; Hepbarna for the treatment of the hepatitis B virus; Tribetarna for treating drug resistant non-small cell lung c... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT